- Preview Available
- Scholarly Journal
Olaparib combined to metronomic cyclophosphamide and metformin in women with recurrent advanced/metastatic endometrial cancer: the ENDOLA phase I/II trial
Nature Communications; London Vol. 16, Iss. 1,  (2025): 1821.
DOI:10.1038/s41467-025-56914-7
This is a limited preview of the full PDF
Try and log in through your library or institution to see if they have access.




